Cancer news source

Filters close
Newswise: PA State Senator Aument Recognized for His Support of Research at SHRO
Released: 11-Sep-2024 10:05 AM EDT
PA State Senator Aument Recognized for His Support of Research at SHRO
Sbarro Health Research Organization (SHRO)

Temple University’s Sbarro Institute for Cancer Research and Molecular Medicine has benefited from the support of Pennsylvania State Sen. Ryan Aument since he took office in 2014.

Newswise: Comprehensive cancer research from Dana-Farber to lead ESMO Congress 2024
9-Sep-2024 8:05 AM EDT
Comprehensive cancer research from Dana-Farber to lead ESMO Congress 2024
Dana-Farber Cancer Institute

Novel treatments, including targeted therapies and antibody drug conjugates, as well as research into improving quality of life for patients with breast cancer, headline studies led by Dana-Farber Cancer Institute and presented at the European Society of Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain.

Released: 10-Sep-2024 4:05 PM EDT
TORL BioTherapeutics Announces Appointment of Howard A. "Skip" Burris III, MD, FACP, FASCO as Board Member
TORL Biotherapeutics LLC

TORL BioTherapeutics, LLC (TORL), a clinical stage biotechnology company discovering and developing new antibody-based immunotherapies to improve and extend the lives of patients with cancer worldwide, today announced the appointment of Howard A. "Skip" Burris III, MD, FACP, FASCO as Board Member.

Newswise: NCCN Policy Summit Explores how to Build an Inclusive Cancer Center Workplace Culture that Better Serves Everybody
Released: 10-Sep-2024 2:00 PM EDT
NCCN Policy Summit Explores how to Build an Inclusive Cancer Center Workplace Culture that Better Serves Everybody
National Comprehensive Cancer Network® (NCCN®)

Speakers at an NCCN Oncology Policy Summit discuss the importance of diversity, equity, and inclusion (DEI) as integral to the oncology workforce to improve cancer outcomes, and what to do about backlash.

access_time Embargo lifts in 2 days
Embargo will expire: 16-Sep-2024 5:00 PM EDT Released to reporters: 10-Sep-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-Sep-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Can Chatbots Help with Genetic Testing for Cancer Risk?
Released: 10-Sep-2024 12:05 PM EDT
Can Chatbots Help with Genetic Testing for Cancer Risk?
Huntsman Cancer Institute at the University of Utah

Demand for cancer genetic testing is on the rise, but there's not enough genetic counselors to guide patients through the process. Researchers say chatbots could be the answer.

Released: 10-Sep-2024 12:00 PM EDT
Expert Available: Doctors Will Now Be Required to Notify Patients About Breast Density Following Mammograms
George Washington University

The Food and Drug Administration has updated mammogram report guidelines, effective today. ...

6-Sep-2024 2:05 PM EDT
New Law Regulating Out-of-Pocket Drug Spending Saves Cancer Patients More Than $7,000 a Year, Study Finds
Michigan Medicine - University of Michigan

As prescription oral chemotherapies have become a common form of cancer treatment, some patients were paying more than $10,000 a year for medications. A new study finds that efforts to cap prescription drug spending are yielding significant out-of-pocket savings for these patients.

Released: 10-Sep-2024 10:00 AM EDT
MD Anderson Research Highlights Special Edition: ESMO 2024
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts.

   
Newswise: Mark Awad Named Chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center
9-Sep-2024 5:00 PM EDT
Mark Awad Named Chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center

Mark Awad, MD, PhD, has been appointed Chief of the Thoracic Oncology Service within the Solid Tumor Oncology Division, Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK).

Newswise: Pausing Biological Clock Could Boost Lab-Produced Blood Stem Cells
Released: 9-Sep-2024 4:05 PM EDT
Pausing Biological Clock Could Boost Lab-Produced Blood Stem Cells
Iowa State University

An Iowa State University research team has discovered when and why inflammatory signaling affects the formation of blood stem cells in embryos, which will benefit efforts to develop lab-grown, patient-derived stem cell transfusions to treat blood disorders. The promising advancement in regenerative medicine could eliminate the need for bone marrow transplants.

Released: 9-Sep-2024 2:05 PM EDT
MD Anderson Research Highlights Special Edition: 2024 World Conference on Lung Cancer
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. This special edition features compelling data on lung cancer advances presented by MD Anderson researchers at the 2024 World Conference on Lung Cancer.

   
Newswise: How the Scars of Demolished Brain Tumors Seed Relapse
Released: 9-Sep-2024 12:05 PM EDT
How the Scars of Demolished Brain Tumors Seed Relapse
Ludwig Cancer Research

A Ludwig Cancer Research study has discovered that recurrent tumors of the aggressive brain cancer glioblastoma multiforme (GBM) grow out of the fibrous scars of malignant predecessors destroyed by interventions such as radiotherapy, surgery and immunotherapy.

Newswise: Pathway Tied to Cancer-Driving Genome Alterations Identified
Released: 9-Sep-2024 11:05 AM EDT
Pathway Tied to Cancer-Driving Genome Alterations Identified
UT Southwestern Medical Center

Cancer cells appear to hijack a genetic pathway involved in DNA repair to drive malignancy and overcome treatment, a study led by UT Southwestern Medical Center researchers shows. Their findings, published in Cell, explain how chromosomes in some tumors undergo massive rearrangements and could lead to new strategies to avoid cancer drug resistance.

Released: 9-Sep-2024 10:05 AM EDT
Cancer Research in Space for Life on Earth: Wake Forest Institute for Regenerative Medicine Selected Through International Space Station National Lab Solicitation in Partnership with NASA
Atrium Health Wake Forest Baptist

The Wake Forest Institute for Regenerative Medicine (WFIRM) is honored to announce its selection for a pioneering cancer research project that will take place aboard the International Space Station (ISS).

Newswise: Researchers Identify Factor That Drives Prostate Cancer-Causing Genes
5-Sep-2024 4:05 PM EDT
Researchers Identify Factor That Drives Prostate Cancer-Causing Genes
Michigan Medicine - University of Michigan

Researchers at the University of Michigan Health Rogel Cancer Center have uncovered a key reason why a typically normal protein goes awry and fuels cancer. They found the protein NSD2 alters the function of the androgen receptor, an important regulator of normal prostate development.

Newswise: Immunotherapy Before and After Lung Cancer Surgery Reduces Death Risk, Disease Recurrence
5-Sep-2024 10:00 AM EDT
Immunotherapy Before and After Lung Cancer Surgery Reduces Death Risk, Disease Recurrence
Johns Hopkins Medicine

People with operable non-small cell lung cancers may fare better over the next few years by receiving immunotherapy treatments before and after surgery instead of only before surgery, according to a new analysis by Johns Hopkins Kimmel Cancer Center investigators.


  • Previous Page
  • Next Page

Showing results

11 of 1

close
4.43412